Literature DB >> 21300016

High frequency of PfCRT 76T in two Malian villages and its prevalence in severe relative to non-severe malaria.

Mamadou Wélé1, Abdoulaye A Djimdé, Aldiouma Guindo, Abdoul H Beavogui, Isaac Z Traoré, Aboubacar Sadou, Dackouo Blaise, Dapa A Diallo, Thomas E Wellems, Ogobara K Doumbo.   

Abstract

We investigated PfCRT 76T mutation in severe and non-severe malaria in Southern Mali. One hundred and ninety three severe malaria cases were each matched against two non-severe malaria cases. Patients with G6PD deficiency and any known hemoglobin abnormality were excluded. PfCRT 76T was present in 60.8% (n=386) non-severe malaria cases and in 77.2% (n=193) severe malaria cases (p<0.0001). In children 5 years or younger, these proportions were 62.9% (n=294) vs. 73.5% (n=147), respectively (p<0.01). PfCRT 76T was therefore associated with malaria severity in this setting of Mali.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21300016      PMCID: PMC4792268          DOI: 10.1016/j.actatropica.2011.01.002

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  16 in total

Review 1.  Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster.

Authors: 
Journal:  Trans R Soc Trop Med Hyg       Date:  2000-04       Impact factor: 2.184

2.  Antimalarial drugs clear resistant parasites from partially immune hosts.

Authors:  P Cravo; R Culleton; P Hunt; D Walliker; M J Mackinnon
Journal:  Antimicrob Agents Chemother       Date:  2001-10       Impact factor: 5.191

3.  Drug resistance-virulence relationship in Plasmodium falciparum causing severe malaria in an area of seasonal and unstable transmission.

Authors:  Hayder A Giha; Mustafa I Elbashir; Ishraga E A-Elbasit; Thoraya M E A-Elgadir; Gehad E ElGhazali; Margaret J Mackinnon; Hamza A Babiker
Journal:  Acta Trop       Date:  2005-12-05       Impact factor: 3.112

4.  Physical linkage to drug resistance genes results in conservation of var genes among West Pacific Plasmodium falciparum isolates.

Authors:  Elizabeth V Fowler; Marina Chavchich; Nanhua Chen; Jennifer M Peters; Dennis E Kyle; Michelle L Gatton; Qin Cheng
Journal:  J Infect Dis       Date:  2006-08-23       Impact factor: 5.226

5.  No variation in the prevalence of point mutations in the Pfcrt and Pfmdr1 genes in isolates from Gabonese patients with uncomplicated or severe Plasmodium falciparum malaria.

Authors:  Pembe Issamou Mayengue; Yvonne Kalmbach; Saadou Issifou; Peter G Kremsner; Francine Ntoumi
Journal:  Parasitol Res       Date:  2006-10-28       Impact factor: 2.289

6.  Return of chloroquine antimalarial efficacy in Malawi.

Authors:  Miriam K Laufer; Phillip C Thesing; Nicole D Eddington; Rhoda Masonga; Fraction K Dzinjalamala; Shannon L Takala; Terrie E Taylor; Christopher V Plowe
Journal:  N Engl J Med       Date:  2006-11-09       Impact factor: 91.245

7.  Chloroquine resistance of Plasmodium falciparum is associated with severity of disease in Nigerian children.

Authors:  P E Olumese; O K Amodu; A Björkman; A A Adeyemo; R A Gbadegesin; O Walker
Journal:  Trans R Soc Trop Med Hyg       Date:  2002 Jul-Aug       Impact factor: 2.184

8.  Impact of chloroquine resistance on malaria mortality.

Authors:  J F Trape; G Pison; M P Preziosi; C Enel; A Desgrées du Loû; V Delaunay; B Samb; E Lagarde; J F Molez; F Simondon
Journal:  C R Acad Sci III       Date:  1998-08

9.  Analysis of Plasmodium falciparum var genes expressed in children from Papua New Guinea.

Authors:  Nicole Falk; Mirjam Kaestli; Weihong Qi; Michael Ott; Kay Baea; Alfred Cortés; Hans-Peter Beck
Journal:  J Infect Dis       Date:  2009-08-01       Impact factor: 5.226

10.  Efficacy of chloroquine, amodiaquine and sulphadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria: revisiting molecular markers in an area of emerging AQ and SP resistance in Mali.

Authors:  Mamadou Tekete; Abdoulaye A Djimde; Abdoul H Beavogui; Hamma Maiga; Issaka Sagara; Bakary Fofana; Dinkorma Ouologuem; Souleymane Dama; Aminatou Kone; Demba Dembele; Mamadou Wele; Alassane Dicko; Ogobara K Doumbo
Journal:  Malar J       Date:  2009-02-26       Impact factor: 2.979

View more
  7 in total

1.  Differential prevalence of transporter polymorphisms in symptomatic and asymptomatic falciparum malaria infections in Uganda.

Authors:  Stephen Tukwasibwe; Levi Mugenyi; George W Mbogo; Sheila Nankoberanyi; Catherine Maiteki-Sebuguzi; Moses L Joloba; Samuel L Nsobya; Sarah G Staedke; Philip J Rosenthal
Journal:  J Infect Dis       Date:  2014-01-19       Impact factor: 5.226

2.  Associations between Aminoquinoline Resistance Genotypes and Clinical Presentations of Plasmodium falciparum Infection in Uganda.

Authors:  Gloria Cuu; Victor Asua; Stephen Tukwasibwe; Sam L Nsobya; Ann Nanteza; Magambo Phillip Kimuda; Arthur Mpimbaza; Philip J Rosenthal
Journal:  Antimicrob Agents Chemother       Date:  2020-09-21       Impact factor: 5.191

3.  High frequency of Plasmodium falciparum chloroquine resistance marker (pfcrt T76 mutation) in Yemen: an urgent need to re-examine malaria drug policy.

Authors:  Abdulsalam M Al-Mekhlafi; Mohammed A K Mahdy; Hesham M Al-Mekhlafi; Ahmed A Azazy; Mun Yik Fong
Journal:  Parasit Vectors       Date:  2011-05-27       Impact factor: 3.876

4.  Surveillance of travellers: an additional tool for tracking antimalarial drug resistance in endemic countries.

Authors:  Myriam Gharbi; Jennifer A Flegg; Bruno Pradines; Ako Berenger; Magatte Ndiaye; Abdoulaye A Djimdé; Cally Roper; Véronique Hubert; Eric Kendjo; Meera Venkatesan; Philippe Brasseur; Oumar Gaye; André T Offianan; Louis Penali; Jacques Le Bras; Philippe J Guérin
Journal:  PLoS One       Date:  2013-10-30       Impact factor: 3.240

5.  Drug resistance mediating Plasmodium falciparum polymorphisms and clinical presentations of parasitaemic children in Uganda.

Authors:  Stephen Tukwasibwe; Patrick Tumwebaze; Melissa Conrad; Emmanuel Arinaitwe; Moses R Kamya; Grant Dorsey; Samuel L Nsobya; Bryan Greenhouse; Philip J Rosenthal
Journal:  Malar J       Date:  2017-03-21       Impact factor: 2.979

6.  Plasmodium vivax and Plasmodium falciparum ex vivo susceptibility to anti-malarials and gene characterization in Rondônia, West Amazon, Brazil.

Authors:  Anna Caroline C Aguiar; Dhelio B Pereira; Nayra S Amaral; Luiz De Marco; Antoniana U Krettli
Journal:  Malar J       Date:  2014-02-28       Impact factor: 2.979

7.  Differential Prevalences of Pfmdr1 Polymorphisms in Symptomatic and Asymptomatic Plasmodium falciparum Infections in Lastoursville: A Rural Area in East-Central Gabon.

Authors:  Steede Seinnat Ontoua; Lady Charlene Kouna; Sandrine Lydie Oyegue-Liabagui; Dominique Fatima Voumbo-Matoumona; Diamella Nancy Moukodoum; Romeo Karl Imboumy-Limoukou; Jean Bernard Lekana-Douki
Journal:  Infect Drug Resist       Date:  2021-07-24       Impact factor: 4.003

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.